UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [ X ]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ]Preliminary Proxy Statement
[ ]Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2))
[X]Definitive Proxy Statement
[ ]Definitive Additional Materials
[ ]Soliciting Material Pursuant to Section 240.14a-12
SCIENTIFIC INDUSTRIES, INC.
-----------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
-----------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules
14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction
applies:
-----------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
-----------------------------------------------------------------
(3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how
it was determined):
-----------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
-----------------------------------------------------------------
(5) Total fee paid:
-----------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which
the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule
and the date of its filing.
(1) Amount previously paid:
-----------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
-----------------------------------------------------------------
(3) Filing Party:
-----------------------------------------------------------------
(4) Date Filed:
-----------------------------------------------------------------
SCIENTIFIC INDUSTRIES, INC.
October 19, 2007
Dear Fellow Stockholders:
You are cordially invited to attend the 2007 Annual Meeting of
Stockholders of Scientific Industries, Inc. which will be held at 11:00 a.m.
(New York time) on Thursday, November 29, 2007 at the Holiday Inn Hotel,
3845 Veterans Memorial Highway, Ronkonkoma, New York 11779.
Information concerning the matters to be considered and voted upon at the
Annual Meeting is set out in the attached Notice of 2007 Annual Meeting of
Stockholders and Proxy Statement.
It is important that your shares be represented at the 2007 Annual Meeting,
regardless of the number of shares you hold and whether or not you plan to
attend the meeting in person. Accordingly, please complete, sign and date
the enclosed proxy card and return it as soon as possible in the accompanying
business reply envelope so that your shares will be represented at the Annual
Meeting. This will not limit your right to vote in person or to attend the
meeting.
Thank you for your continued support.
Sincerely,
/s/ Joseph G. Cremonese
_______________________
Joseph G. Cremonese
Chairman
SCIENTIFIC INDUSTRIES, INC.
70 Orville Drive
Bohemia, New York 11716
_____________
NOTICE OF 2007 ANNUAL MEETING OF STOCKHOLDERS
NOVEMBER 29, 2007
Notice is hereby given that the 2007 Annual Meeting of Stockholders
(the "Annual Meeting") of Scientific Industries, Inc., a Delaware
corporation (the "Company"), will be held on Thursday, November 29, 2007,
at 11:00 a.m. (New York time) at the Holiday Inn Hotel, 3845 Veterans
Memorial Highway, Ronkonkoma, New York, 11779, for the following purposes:
1. To elect two Class B Directors to the Company's Board of Directors
to serve until the Company's annual meeting of stockholders with
respect to the year ending June 30, 2010 and until the election and
qualification of their respective successors.
2. To ratify the appointment of Nussbaum Yates Berg Klein & Wolpow, LLP
(formerly Nussbaum, Yates & Wolpow, P.C.) as the Company's
independent registered public accounting firm for the fiscal year
ending June 30, 2008.
3. To transact such other business as may properly come before the
Annual Meeting and any adjournments or postponements thereof.
The foregoing items of business are more fully described in the
accompanying proxy statement.
The Board of Directors has fixed the close of business on October 18,
2007, as the record date for determination of stockholders entitled to
notice of and to vote at, the Annual Meeting and at any adjournments or
postponements thereof.
A complete list of the stockholders entitled to vote at the Annual
Meeting will be available for inspection by any stockholder of the Company
at the Annual Meeting. In addition, the list will be open for examination
by any stockholder of the Company for any purpose germane to the Annual
Meeting during ordinary business hours for a period of ten days prior to
the Annual Meeting at the offices of the Company.
You are requested to fill in and sign the enclosed form of proxy,
which is being solicited by the Board of Directors of the Company, and
mail it promptly in the enclosed postage paid envelope. Any proxy may
be revoked by delivery of a later dated proxy.
By Order of your Board of Directors,
/s/ Robert P. Nichols
_____________________
Robert P. Nichols
Secretary
Bohemia, New York
October 19, 2007
WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING, WE KINDLY REQUEST
THAT YOU PLEASE COMPLETE, SIGN, DATE, AND PROMPTLY RETURN THE ENCLOSED
PROXY CARD IN THE POSTAGE PAID ENVELOPE PROVIDED. IF YOU ARE A
STOCKHOLDER OF RECORD AND YOU ATTEND THE ANNUAL MEETING, YOU MAY VOTE
IN PERSON IF YOU WISH, EVEN IF YOU HAVE PREVIOUSLY RETURNED YOUR PROXY
CARD.
YOUR VOTE IS IMPORTANT
SCIENTIFIC INDUSTRIES, INC.
70 Orville Drive
Bohemia, New York 11716
PROXY STATEMENT
_________________
2007 ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON NOVEMBER 29, 2007
_________________
Solicitation of Proxies
This proxy statement is furnished in connection with the solicitation
of proxies by and on behalf of the Board of Directors (the "Board") of
Scientific Industries, Inc., a Delaware corporation (the "Company"),
for use at the 2007 Annual Meeting of Stockholders (the "Annual Meeting")
to be held at the Holiday Inn Hotel, 3845 Veterans Memorial Highway,
Ronkonkoma, New York, 11779, on Thursday, November 29, 2007, at 11:00
a.m. (New York time), and at any adjournments or postponements thereof.
At the Annual Meeting, stockholders of the Company will be asked to:
(1) elect two Directors of the Company to serve until the Company's annual
meeting of stockholders with respect to the fiscal year ending June 30, 2010,
and the election and qualification of their respective successors; (2) ratify
the appointment of Nussbaum Yates Berg Klein & Wolpow, LLP (formerly Nussbaum,
Yates & Wolpow, P.C.), as the Company's independent registered public
accounting firm for the fiscal year ending June 30, 2008; and (3) transact
such other business as may properly come before the Annual Meeting and any
adjournments or postponements thereof.
Record Date, Voting Rights
Only stockholders of record of the Company's Common Stock, par value
$0.05 per share (the "Common Stock"), as of the close of business on
October 18, 2007 (the "Record Date"), are entitled to notice of and to vote
at the Annual Meeting and any adjournments or postponements thereof.
On the Record Date, there were 1,145,352 shares of Common Stock issued and
outstanding. Each share of Common Stock is entitled to one vote.
The presence at the Annual Meeting, in person or by a properly executed
proxy, of the holders of a majority of the outstanding shares of the
Company's Common Stock as of the Record Date is necessary to constitute a
quorum. Abstentions and broker "non-votes" are included in the determination
of the number of shares of Common Stock present at the Annual Meeting for
quorum purposes. A broker "non-vote" occurs when a nominee holding shares of
Common Stock for a beneficial owner does not vote on a particular proposal
because the nominee does not have discretionary voting power with respect
to that item and has not received instructions from the beneficial owner.
Voting of Proxies, Revocation, Solicitation
All stockholders who deliver properly executed and dated proxies to the
Company prior to the Annual Meeting will be deemed present at the Annual
Meeting regardless of whether such proxies direct the proxy holders to vote
for or against, or to withhold or abstain from voting. The proxies, when
properly executed and returned to the Company, will be voted in accordance
with the instructions given therein by the person executing the proxy.
In the absence of instructions, properly executed proxies will be voted FOR
(1) the election of the Board's nominees, Joseph I. Kesselman and Grace S.
Morin, as Directors of the Company; and (2) the ratification of the
appointment by the Board of Directors of Nussbaum Yates Berg Klein & Wolpow,
LLP, as the Company's independent registered public accounting firm for the
fiscal year ending June 30, 2008.
Any stockholder who executes and delivers a proxy may revoke it at any
time before it is voted by delivering a written notice of such revocation to
the Secretary of the Company at the address of the Company set forth in this
proxy statement, by submitting a properly executed proxy bearing a later date,
or by appearing at the Annual Meeting and requesting the return of the proxy
or by voting in person. In accordance with applicable rules, boxes and
designated spaces are provided on the proxy card for stockholders to mark if
they wish either to vote for or withhold authority to vote for the nominees
for Directors, or to vote for or against or to abstain from voting for the
proposal to ratify the appointment of the Company's independent registered
public accounting firm.
A stockholder's attendance at the Annual Meeting will not, by itself,
revoke a proxy given by that stockholder. Stockholders vote at the Annual
Meeting by casting ballots (in person or by proxy), which are tabulated by
a person who is appointed by the Board of Directors before the Annual Meeting
to serve as inspector of election at the Annual Meeting and who has executed
and verified an oath of office.
It is anticipated that this proxy statement, the enclosed proxy card and
the Company's Annual Report will be mailed to the Company's stockholders
on or about October 26, 2007.
PRINCIPAL STOCKHOLDERS
The following table sets forth as of October 18, 2007 certain information
as to each person who to the Company's knowledge, based upon such person's
representations or publicly available filings, beneficially owned more than
5% of the outstanding shares of the Company's Common Stock as of that date:
Name and Address of Shares Beneficially Percent of
Beneficial Owner Owned** Class***
___________________ ___________________ __________
James S. Segasture* 187,250 (1) 16.3
Lowell A. Kleiman 139,581 (2) 12.2
16 Walnut Street
Glen Head, NY 11545
Grace S. Morin* 112,950 9.9
Joseph I. Kesselman* 64,120 (3) 5.5
Arthur M. Borden* 60,740 (4) 5.2
______________
* The address is c/o Scientific Industries, Inc., 70 Orville Drive,
Bohemia, New York 11716.
** Beneficial ownership, as such term is used herein, is determined in
accordance with Rule 13d-3(d)(1) promulgated under the Securities Exchange
Act of 1934, as amended, (the "Exchange Act") and includes voting and/or
investment power with respect to shares of Common Stock of the Company.
Unless otherwise indicated, the named person possesses sole voting and
investment power with respect to the shares. The shares shown include
shares issuable pursuant to options held by the named person that may
be exercised within 60 days of the date indicated above.
*** Percentages of ownership are based upon the number of shares of
Common Stock issued and outstanding. Shares of Common Stock that may
be acquired pursuant to options that are exercisable within 60 days of
the date indicated above are deemed outstanding for computing the
percentage ownership of the person holding such options, but are not
deemed outstanding for the percentage ownership of any other person.
(1) Includes 4,000 shares issuable upon exercise of options and 493
shares owned by his wife.
(2) Based on information reported in his Schedule 13(d) filed with
the Securities and Exchange Commission on October 30, 2002.
(3) Includes 16,000 shares issuable upon exercise of options, 735
shares of Common Stock owned jointly with his wife, and 4,000 shares
of Common Stock owned by his wife.
(4) Includes 20,000 shares issuable upon exercise of options.
PROPOSAL 1
ELECTION OF DIRECTORS
General
_______
The Company's Certificate of Incorporation provides for a
classified Board of Directors, consisting of three classes, each class
serving a three-year term on a staggered basis. The Board of Directors is
currently comprised of six members, of whom two are Class A Directors,
two are a Class B Directors and two are Class C Directors. At the Annual
Meeting, two Class B Directors are to be elected to serve until the annual
meeting of stockholders with respect to the fiscal year ending June 30, 2010,
and until their successors are duly elected and qualified. Shares of
Common Stock represented by proxies solicited by the Board of Directors
will be voted for the nominees hereinafter named if authority to do so is
not specifically withheld. If for any reason said nominees shall become
unavailable for election, which is not now anticipated, the proxies will
be voted for a substitute nominee designated by the Board of Directors.
The Directors of the Company are elected by the affirmative vote
of the holders of a plurality of the shares of Common Stock present in
person or represented by proxy at the Annual Meeting and entitled to vote.
A plurality means that the nominee with the largest number of votes is
elected as Director. In tabulating the vote, abstentions and broker "non-
votes" will be disregarded and will have no effect on the outcome of
the vote.
The Board of Directors recommends that stockholders vote FOR the
election of the nominees identified below to the Board of Directors.
Nominees
________
The Board of Directors has designated Mr. Joseph I. Kesselman and
Ms. Grace S. Morin, both currently Class B Directors, as their nominees
for election.
Grace S. Morin (age 59 ), a Director since December 4, 2006,
had been from December 2003 President, Director and principal stockholder
of Altamira Instruments, Inc. until its acquisition by the Company on
November 30, 2006. Ms. Morin has been engaged by Altamira Instruments, Inc.
("Altamira") on a part-time basis to supervise the administrative functions
for the Company's Catalyst Research Instruments operations in the Pittsburgh,
Pennsylvania facility. Prior to December 2003, she was a general business
consultant for two years, and prior to that she was a member of senior
management of a designer of gas flow environmental engineered products for
approximately four years.
Joseph I. Kesselman (age 82), a Director since 1961 and Chairman of
the Board from August 2002 until his resignation in February 2006, has been
for more than five years a consultant to various corporations. He is a
director of Nuclear and Environmental Protection Inc., Hopare Holding,
S.A. (a Swiss company), and Infranor Inc., a developer and manufacturer
of servo systems.
Other Directors
_______________
Class A Directors:
Arthur M. Borden, Esq. (age 87), a Director since 1974, has been
counsel to the law firm of Katten Muchin Rosenman LLP (formerly Rosenman
& Colin) during the past five years. He is a director of Supreme
Industries, Inc., a nationwide manufacturer of specialized truck bodies.
James S. Segasture (age 71), a Director since 1991, has been a
private investor since February 1990.
Class C Directors:
Joseph G. Cremonese (age 71), a Director since November 2002 and
Chairman of the Board since February 2006, has been a marketing consultant
to the Company since 1996. Mr. Cremonese has been since 1991, President
of Laboratory Innovation Company, Ltd., which is a vehicle for technology
transfer and consulting services for companies, including the Company,
engaged in the production and sale of products for science and biotechnology.
Since March 2003, Mr. Cremonese has been a director of and consultant to
Proteomics, Inc., a producer of recombinant proteins for medical research.
Prior to 1991, he had been employed by Fisher Scientific, the largest U.S.
distributor of laboratory equipment, which had been for many years
through fiscal 2006, the Company's major customer.
Roger B. Knowles (age 82), a Director since 1965, is retired.
During the past five years he has been involved in liquidating various
real estate and manufacturing concerns.
Stock Ownership
The following table sets forth, as of October 18, 2007, the
number of shares of Common Stock beneficially owned by (i) each Director
of the Company, including the nominees for Directors, (ii) each executive
officer of the Company identified in the Summary Compensation Table under
"Executive Officers," and (iii) all directors and executive officers as a group.
Beneficial Owner Number Percentage
________________ __________ __________
Arthur M. Borden 60,740 (1) 5.2%
Joseph G. Cremonese 31,410 (2) 2.7%
Joseph I. Kesselman 64,120 (3) 5.5%
Roger B. Knowles 25,595 (4) 2.2%
Grace S. Morin 112,950 9.9%
James S. Segasture 187,250 (5) 16.3%
Helena R. Santos 18,000 (6) 1.6%
Robert P. Nichols 27,800 (7) 2.4%
All current directors
and executive officers as a
group (8 persons) 527,865 (8) 42.4%
(1) Includes 20,000 shares issuable upon exercise of options.
(2) Includes 21,410 shares owned jointly with his wife and 10,000
shares issuable upon exercise of options.
(3) Includes 16,000 shares issuable upon exercise of options,
735 shares of Common Stock owned jointly with his wife, and 4,000
shares of Common Stock owned by his wife.
(4) Includes 4,258 shares owned by his wife, 1,337 shares owned
by a trust of which he is a trustee, beneficial ownership of which
is disclaimed by him, and 20,000 shares issuable upon exercise of
options.
(5) Includes 4,000 shares issuable upon exercise of options and
493 shares owned by his wife.
(6) Includes 5,000 shares issuable upon exercise of options.
(7) Includes 25,000 shares issuable upon exercise of options.
(8) Includes 100,000 shares issuable upon exercise of options.
Board Committees
________________
Joseph I. Kesselman and James S. Segasture have been appointed
as the sole members of the Company's Stock Option Committee to serve
at the discretion of the Board and to administer the Company's 2002
Stock Option Plan ("2002 Plan").
Grace S. Morin, Joseph I. Kesselman, and James S. Segasture
have been appointed as the members of the Company's Compensation
Committee to serve at the discretion of the Board and to administer
the Company's Compensation policies.
The Board of Directors acts as the Company's Audit Committee.
The Company does not have a financial expert on the Audit
Committee as defined by the Securities and Exchange Commission;
however, the Company believes that the members of the Audit Committee
have sufficient knowledge to properly evaluate and analyze the
Company's financial statements.
Meetings
________
During the fiscal year ended June 30, 2007 ("fiscal 2007"),
the Board of Directors held five meetings, at each of which all
persons who were Directors at the time were present.
Directors' Compensation and Options
___________________________________
DIRECTORS' COMPENSATION
____________________________________________________________________
Non-
Equity
Fees Incentive
Earned Plan
or Paid Stock Option Comp-
in Cash Awards Awards ensation
Name ($) ($) ($) ($)
(a) (b) (c) (d) (e)
_____________________________________________________________________
Arthur M.
Borden 7,250 0 0 0
Joseph G.
Cremonese 17,000 0 10,100 0
Joseph I.
Kesselman 7,250 0 0 0
Roger B.
Knowles 7,250 0 0 0
Grace S.
Morin 0 0 0 0
James S.
Segasture 7,250 0 0 0
____________________________________________________________________
DIRECTORS' COMPENSATION (CONTINUED)
____________________________________________________________________
Non-
qualified
Deferred All
Comp- Other
ensation Comp-
Earnings ensation Total
Name ($) ($) ($)
(a) (f) (g) (h)
____________________________________________________________________
Arthur M. 0 0 7,250
Borden
Joseph G.
Cremonese 0 (1) 27,100(1)
Joseph I.
Kesselman 0 0 7,250
Roger B.
Knowles 0 0 7,250
Grace S.
Morin 0 (2) (2)
James S.
Segasture 0 0 7,250
____________________________________________________________________
(1) Mr. Cremonese received additional compensation amounting to $32,900
for fiscal 2007 under a separate agreement with the Company for marketing
consulting services as described under "Related Transactions".
(2) Ms. Morin, as an employee-director does not receive director
compensation; however, since November 30, 2006, she received $41,000
in compensation as an employee of Altamira.
As of April 1, 2007, the Company increased its quarterly retainer
fees to its Directors from $750 to $1,500 and for each meeting attended
from $500 to $1,000. In addition, the Company reimburses each Director
for out-of-pocket expenses incurred in connection with attendance at
board meetings in the amount of $50 or the Director's itemized expenses,
whichever is greater. Mr. Joseph I. Kesselman as Chairman of the Board
until February 2006 received $750 per month, and Mr. Joseph G. Cremonese,
as Chairman of the Board, since February 2006 received $750 per month
until April when the monthly fee was increased to $1,000. During
fiscal 2007, the fees to non-employee Directors aggregated $46,000.
Pursuant to the Company's 1992 Stock Option Plan ("1992 Plan") options
to purchase 3,000 shares of Common Stock at the then fair market value
were granted to each non-employee director who was on the Board of Directors
on the first business day of each March, in 1993, 1994, 1995, and 1996,
namely Messrs. Borden, Kesselman, Knowles and Segasture. In addition, in
December 1997 and through December 2002 the Board of Directors granted
under the 1992 Plan annually options to purchase 4,000 shares of Common Stock
to each of them exercisable at the fair market value on the date of grant.
Accordingly, as of June 30, 2007, the Company had granted under the 1992
Plan to the foregoing four non-employee Directors options to purchase an
aggregate of 128,000 shares of Common Stock, or options to purchase 32,000
shares of Common Stock for each. The fair market value per share of Common
Stock on the dates of grant ranged from $0.50 for options granted in 1993 to
$2.40 in 2002. As of June 30, 2007, options under the 1992 Plan with
respect to 68,000 shares had been exercised by the Directors. In addition,
they had exercised options with respect to 48,000 shares granted to them
prior to the adoption of the 1992 Plan.
Under the Company's 2002 Plan, none of the Directors at the time of the
adoption by the Board of Directors of the 2002 Plan (subsequently approved
by stockholders) were eligible to receive option grants. Mr. Joseph G.
Cremonese who was elected Director at the 2002 Annual Meeting of Stockholders,
was granted on December 1, 2003 an option to purchase 5,000 shares of Common
Stock at the fair market value of $1.35 per share, and, on February 20, 2007
an option to purchase 5,000 shares of Common Stock at the fair market value of
$3.10 per share.
Executive Officers
__________________
The following are the Executive Officers of the Company:
Helena R. Santos, CPA (age 43), employed by the Company since 1994,
was appointed in August 2002 as President, Chief Executive Officer and
Treasurer. Previously she served as Vice President, Controller from
1997 and Secretary from May 2001. Ms. Santos was an internal auditor
with a major defense contractor from March 1991 to April 1994. She had been
previously employed in public accounting.
Robert P. Nichols (age 46), employed by the Company since February
1998, was appointed in August 2002 as Executive Vice President. He had
been Vice President, Engineering from May 2001. Prior to joining the
Company, Mr. Nichols was an Engineer Manager with Bay Side Motion Group,
a precision motion equipment manufacturer, from January 1996 to
February 1998.
The executive officers of the Company are elected by the Board of
Directors and hold office until their respective successors are
elected and qualified or until his or her earlier resignation or removal.
None of the officers need to be Directors, and more than one office
may be held by the same person. There is no arrangement or understanding
between any executive officer and any person other than the Company
regarding election as an officer. There are no family relationships
between any Director and any executive officer of the Company.
On December 29, 2006, the Company entered into new employment
agreements with Ms. Helena R. Santos and Mr. Robert P. Nichols
replacing employment agreements that were entered into in September 2004.
The new agreements increased their base annual salaries by $10,000 each -
to $120,000 for Ms. Santos and $115,000 for Mr. Nichols. The new
agreements also extended their employment period to December 31, 2008.
They otherwise contain substantially the same provisions as the replaced
agreements, including annual bonuses at the discretion of the Board and
non-competition and confidentiality covenants. The Board awarded
a $10,000 bonus to each of Ms. Santos and Mr. Nichols on December 4, 2006
which was paid on December 31, 2006.
The Compensation Committee along with the other members of the Board
reviews and determines the compensation payable to executives. In making
a determination, the Committee and the Board give material consideration
to the Company's results of operations and financial condition and
competitive factors. The compensation at times includes grants of
options under its stock option plan to the named executive, each subject
to long-term employment agreements, containing terms which the Board of
Directors deemed reasonable. The Board is cognizant that as a relatively
small company, the Company has limited resources and opportunities with
respect to recruiting and retaining key executives. Accordingly, the
Company has relied upon long-term employment agreements to retain
qualified personnel.
The following table summarizes all compensation paid by the Company to
its then Chief Executive Officer ("CEO"), Chief Financial Officer ("CFO"),
and President; and Executive Vice President with respect to each of the
three fiscal years ended June 30, 2007, 2006 and 2005. No other executive
officer earned in excess of $100,000 in any of such fiscal periods.
SUMMARY COMPENSATION TABLE
_____________________________________________________________
Non-
Equity
Incentive
Name Plan
and Stock Option Comp-
Principal Fiscal Salary Bonus Awards Awards ensation
Position Year ($) ($) ($) ($) ($)
(a) (b) (c) (d) (e) (f) (g)
_____________________________________________________________
Helena R. 2007 115,000 10,000 0 0 0
Santos, 2006 112,100 0 0 0 0
CEO, 2005 108,200 0 0 0 0
President,
CFO
Robert P. 2007 110,000 10,000 0 0 0
Nichols, 2006 107,000 0 0 0 0
Exec. 2005 103,200 0 0 0 0
V. P.
_____________________________________________________________
SUMMARY COMPENSATION TABLE (CONTINUED)
_____________________________________________________________
Non-
Qualified
Deferred All
Name Comp- Other
and ensation Comp-
Principal Earnings ensation Total
Position ($) ($) ($)
(a) (h) (i) (j)
_____________________________________________________________
Helena R. 2007 2,500(1) 127,500
Santos, 2006 2,200(1) 114,300
CEO, 2005 2,200(1) 110,400
President,
CFO
Robert P. 2007 2,400(1) 122,400
Nichols, 2006 2,100(1) 109,100
Exec. 2005 2,100(1) 105,300
V. P.
_____________________________________________________________
(1)Represents the Company's matching contribution under the
Company's 401(K) Plans.
(1)Represents the Company's matching contribution under the Company's
401(K) Plans.
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
_____________________________________________________________
Option Awards
_____________________________________________________________
Number
Number of
of Securities
Securities Under-
Under- lying
lying Unexercised Option
Exercised Options(#) Exercise Option
Options(#) Unexerci- Price Expiration
Name Exercisable sable ($) Date
(a) (b) (c) (e) (f)
_____________________________________________________________
Helena R. 5,000 0 .84 5/2009
Santos
Robert P. 25,000 0 1.45 (1)
Nichols
_____________________________________________________________
(1) 12,000 shares expire in March 2008; 8,000 shares expire
May 2009; and 5,000 shares expire October 2012.
Option Grants in Last Fiscal Year
There were no options granted to officers during fiscal 2007.
Aggregated Option Exercises in Last Fiscal Year and FY-End Option Values
Number of
Shares of Securities Value of
Common Underlying Unexercised
Stock Unexercised in-the-money
Acquired Options Options
On Value at FY-End (#) at FY-End ($)
Exercise Realized Exercisable/ Exercisable/
Name (#) ($)(1) Unexercisable Unexercisable(1)
________________________________________________________________________
Helena R. Santos 10,000 16,500 5,000/0 12,530/0
(1) Calculated by multiplying the number of shares of Common Stock
subject to options by the difference between the market price and
exercise price, per share, on date of exercise, and June 30, 2007,
respectively.
Related Transactions
____________________
Mr. Joseph G. Cremonese, who was first elected a Class C Director at
the Annual Meeting of Stockholders in November 2002 through his affiliate,
Laboratory Innovation Company, Ltd., has been providing independent
marketing consulting services to the Company for approximately ten
years. Commencing January 1, 2003, the services have been rendered
pursuant to a consulting agreement which was amended and restated for a
second time in March 2007. The agreement as amended and restated
provides that Mr. Cremonese and his affiliate render, at the request of the
Company, through December 31, 2008 marketing consulting services of at
least 60, but not more than 96, days per year at the rate of $600 per day
with a monthly payment of $3,000, with the Company's obligation reduced
to the extent the consulting services are less than 60 days for the
12 month period. The agreement contains confidentiality and non-competition
covenants. During fiscal 2007, the Company paid an aggregate of $32,900
for the consulting services.
Pursuant to the Altamira acquisition, Ms. Morin, a former 90.4%
owner of the capital stock of Altamira, received $361,440 in cash, 112, 950
shares of the Common Stock of the Company and the right to receive 90.4%
of 5% as adjusted, of the net sales of Altamira for each of the following
five periods - December 1, 2006 to June 30, 2007, each of the 12 month
periods ending respectively on June 30, 2008, June 30, 2009, and
June 30, 2010; and July 1, 2010 to November 30, 2010. The payment to Ms.
Morin for the first period amounted to $59,700. The Company and Ms. Morin
and the other sellers agreed to the filing by the Company of an election
under Section 338 of the Internal Revenue Code to treat the acquisition as
a purchase for tax purposes within the meaning of the Code ("Code") and the
Company agreed to reimburse them for any tax consequences resulting from
such election. Accordingly, in September 2007, the Company paid Ms. Morin
$39,800 and $2,200 to the other selling stockholders in reimbursement.
In connection with the Altamira transaction, the Company agreed to have
Altamira continue to employ Ms. Morin for up to 90 days. However, due to
operational needs, she has been employed on a part-time basis since May 1,
2007 to supervise the on-site administrative duties.
In connection with the Altamira acquisition, Altamira entered into a
two-year employment agreement with Mr. Brookman March, husband of Ms. Morin,
who was prior to the acquisition Altamira's Vice President and a director,
employing him as Director of Marketing and Operations. The employment
agreement provides for a two year term at a salary of $110,000 per annum with
Altamira having two one-year renewal options, at a salary increase of 2%
during each renewal period plus adjustments based on annual increases in the
consumer price index.
Section 16(a) Reporting
_______________________
The Company believes that, for the year ended June 30, 2007, its
officers, directors and 10% stockholders timely complied with all filing
requirements of Section 16(a) of the Securities Exchange Act of 1934,
as amended.
PROPOSAL 2
APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors, subject to stockholders' approval,
appointed Nussbaum Yates Berg Klein & Wolpow, LLP (the "Firm")
(formerly Nussbaum, Yates & Wolpow, P.C.) as the Company's independent
registered public accounting firm of the Company for its financial
statements for fiscal year ending June 30, 2008. The Firm has audited
the consolidated financial statements of the Company since 1991.
A representative of the Firm is expected to be present at the Annual
Meeting, and will have an opportunity to make a statement to the
stockholders and will be available to respond to appropriate questions.
The ratification of the appointment will require the affirmative vote
of the holders of a majority of the outstanding shares of Common Stock
present in person or represented by proxy at the Annual Meeting and
entitled to vote. Abstentions will be included in determining the
number of shares of Common Stock present or represented and entitled
to vote for purposes of approval and will have the effect of votes
"against" the proposal. Broker "non-votes" will not be counted in
determining the number of shares of Common Stock present or represented
and entitled to vote to approve the proposal and will therefore not have
the effect of votes either "for" or "against".
Stockholder ratification of the appointment is not required by
the Company's Certificate of Incorporation or By-laws or otherwise.
If the stockholders fail to ratify the appointment, the Board of
Directors will reconsider whether to retain that firm. Even if the
appointment is ratified, the Board of Directors in its discretion may
direct the appointment of a different independent registered public
accounting firm at any time during the year if the Board of Directors
determines that such a change would be in the best interests of the
Company and its stockholders.
The following is a description of the fees incurred by the Company
for services by the Firm during fiscal 2007 and the fiscal year ended
June 30, 2006 ("fiscal 2006").
Audit Fees: The Company incurred fees of the Firm of
approximately $35,000 and $24,500 in connection with its audit of the
Company's financial statements for fiscal 2007 and fiscal 2006, and
$4,500 and $2,850 in connection with the review of the Company's
interim financial statements included in the Company's Quarterly
Reports on Form 10-QSB during the fiscal 2007 and fiscal 2006,
respectively.
Tax Fees: The Company incurred fees of the Firm of
approximately $4,000 for each of fiscal 2007 and fiscal 2006, in
connection with preparation of the corporate tax returns.
Financial Information Systems Design and Implementation Fees:
The Firm was not engaged by the Company during either fiscal 2007 or
fiscal 2006 to provide advice regarding financial information systems
design and implementation.
Other Fees: The Company paid $39,900 in fiscal 2007 to the Firm
in connection with the acquisition of Altamira. The Firm did not
perform other non-audit services in fiscal 2006.
The Board of Directors unanimously recommends that the stockholders vote
FOR the ratification of the appointment of Nussbaum Yates Berg Klein &
Wolpow, LLP as the Company's independent registered public accounting
irm for the fiscal year ending June 30, 2008.
OTHER MATTERS
The Board of Directors is not aware of any matters other than
those set forth in this proxy statement that will be presented for action
at the Annual Meeting; however, if any other matters properly come before
the Annual Meeting, the persons named as proxies intend to vote the shares
of Common Stock they represent in accordance with their judgment on such
matters.
ADDITIONAL INFORMATION
The Company's Annual Report to Stockholders for the fiscal year
ended June 30, 2007, includes its Annual Report on Form 10-KSB for the year
which was filed with the U.S. Securities and Exchange Commission on September
28, 2007. The Annual Report to Stockholders on Form 10-KSB is not part of
this proxy material, but is being mailed to stockholders with this proxy
solicitation.
STOCKHOLDER PROPOSALS
Proposals of stockholders of the Company intended to be presented
at the Company's Annual Meeting of Stockholders following the year ending
June 30, 2008 must be received by the Secretary of the Company for inclusion
in the appropriate proxy materials no later than July 7, 2008.
EXPENSES AND SOLICITATION
The entire cost of soliciting proxies will be borne by the Company.
In addition to the use of the mails, proxies may be solicited by officers,
directors and regular employees of the Company personally or by telephone.
No additional compensation will be paid to such persons for any additional
solicitations. The Company will also request securities brokers, custodians,
nominees and fiduciaries who hold shares of Common Stock of record to forward
solicitation material to the beneficial owners of such shares, and will
reimburse them for their reasonable out-of-pocket expenses in forwarding such
soliciting materials.
By Order of your Board of Directors,
/s/Robert P. Nichols
____________________
Robert P. Nichols
Secretary
Bohemia, New York
October 19, 2007
____________________________________________________________________________
SCIENTIFIC INDUSTRIES, INC.
PROXY FOR ANNUAL MEETING OF STOCKHOLDERS
November 29, 2007
THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS
The undersigned hereby appoints Joseph G. Cremonese and Helena R.
Santos, and each of them, with full power of substitution, to vote,
as a holder of the common stock, par value $0.05 per share
("Common Stock"), of Scientific Industries, Inc., a Delaware corporation
(the "Company"), all the shares of Common Stock which the undersigned is
entitled to vote, through the execution of a proxy with respect to the 2007
Annual Meeting of Stockholders of the Company (the "Annual Meeting"), to be
held at the Holiday Inn Hotel, 3845 Veterans Memorial Highway, Ronkonkoma,
New York, on Thursday, November 29, 2007 at 11:00 a.m. New York time, and
any and all adjournments or postponements thereof, and authorizes and
instructs said proxies to vote in the manner directed below.
The Board of Directors recommends the vote FOR the election of the
nominees for Class B Directors named below and proposal 2.
1. Election of Class B Directors: JOSEPH I. KESSELMAN GRACE S. MORIN
FOR both nominees ( ) WITHHOLD for both nominees ( )
If you do not wish your shares voted FOR one of the two nominees, draw a line
through that person's name above.
2. Proposal to ratify the appointment of Nussbaum Yates Berg Klein & Wolpow,
LLP, as the independent registered public accounting firm of the Company for
the fiscal year ending June 30, 2008.
FOR ( ) AGAINST ( ) ABSTAIN ( )
3. In their discretion, the proxies are authorized to vote upon such other
business as may properly come before such meeting or adjournment or
postponement thereof.
THIS PROXY IS CONTINUED ON THE REVERSE SIDE, PLEASE VOTE, SIGN AND DATE ON
REVERSE SIDE AND RETURN PROMPTLY.
__________________________________________________________________________
(BACK OF CARD)
PROPERLY EXECUTED AND RETURNED PROXY CARDS WILL BE VOTED IN THE MANNER
DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO INSTRUCTIONS TO THE
CONTRARY ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF EACH OF THE
NAMED NOMINEES AS DIRECTORS AND APPROVAL OF PROPOSAL NO. 2 LISTED ON THE
REVERSE SIDE OF THIS CARD.
You may revoke this proxy at any time before it is voted by (i) filing
a revocation with the Secretary of the Company, (ii) submitting a duly
executed proxy bearing a later date or time than the date or time of
the proxy being revoked; or (iii) attending the Annual Meeting and
voting in person. A stockholder's attendance at the Annual
Meeting will not by itself revoke a proxy given by the stockholder.
(Please sign exactly as the name appears
hereon. Joint owners should each sign. When
signing as attorney, executor, administrator,
trustee or guardian, please give full title as
such. If a corporation, please sign with full
corporate name by the president or other
authorized officer. If a partnership, please
sign in the partnership name by authorized
person.)
Dated:___________,2007 _______________________________
Signature
PLEASE COMPLETE, SIGN, DATE __________________________________
AND RETURN THE PROXY CARD Signature, if held by joint owners
PROMPTLY USING THE
ENCLOSED ENVELOPE.